Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CytoGenix Announces Completion of synDNA(TM) Production Module Prototype.


HOUSTON -- CytoGenix, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:CYGX) announced that the prototype version of the synDNA(TM) production module was completed on schedule.

The device was designed specifically for the commercial production of cell-free DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 by the leading international biopharmaceutical plant design, engineering and construction firm of Alfa Laval Alfa Laval AB is a Swedish company, founded in 1883 by Gustaf de Laval and Oscar Lamm. The company is a leading producer of specialized products and solutions used to heat, cool, separate and transport products such as oil, water, chemicals, beverages, foodstuffs, starch and  Biokinetics, Philadelphia, Pennsylvania. It was tested by Alfa Laval engineers and CytoGenix senior scientists. The final version will be mounted on a stainless steel stainless steel: see steel.
stainless steel

Any of a family of alloy steels usually containing 10–30% chromium. The presence of chromium, together with low carbon content, gives remarkable resistance to corrosion and heat.
 cart and have the capacity to produce up to 10 grams of high-purity DNA in 24 hours.

Kurt Berens, CytoGenix, Inc. Vice President of Product Development, commented, "This is an important step in our overall plan to construct a cGMP manufacturing facility. We plan to install several synDNA(TM) production modules to meet the growing demand for clinical-grade DNA internally and from customers."

About CytoGenix: CytoGenix, Inc. is a Houston-based biopharmaceutical company that develops and markets innovative products and services based on its proprietary ssDNA expression technology. The company has developed a breakthrough synthetic process for large-scale production of high purity Purity: see Pearl, The.
Purity
See also Modesty.

almond

symbol of the Virgin Mary’s innocence. [O.T.: Numbers 17: 1–11; Art: Hall, 14]

crystal

its transparency symbolizes pureness.
 DNA at a fraction of the cost of traditional fermentation fermentation, process by which the living cell is able to obtain energy through the breakdown of glucose and other simple sugar molecules without requiring oxygen. Fermentation is achieved by somewhat different chemical sequences in different species of organisms.  methods. CytoGenix currently has one issued US patent and 41 international or US pending patent applications claiming methods and materials in connection with this platform technology.

SAFE HARBOR Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission.

Additional information about CytoGenix and its technology can be found on the website at www.cytogenix.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Dec 22, 2005
Words:299
Previous Article:Schaeffer's Midday Options Update Features Verizon Communications, Research in Motion Limited, Barrick Gold, Placer Dome, and Yahoo!
Next Article:Mirant to Deploy Enterprise-wide Environmental Compliance Management System from ESP; New Software System to Provide Streamlined Environmental...
Topics:



Related Articles
CYTOGENIX PATENT PORTFOLIO GROWS AND GOES INTERNATIONAL.
Toyo Tire & Rubber Launches Prototype Tire Production at American Subsidiary.
CytoGenix and Aldevron Announce Positive Results of synDNA(TM) Hepatitis Vaccine Study.
CytoGenix Announces Results of Influenza synDNA(TM) Vaccine Trial.
Alfa Laval Biokinetics Announces Delivery of CytoGenix DNA Production Module.
CytoGenix Receives Re-Supply Order for synDNA(TM).
CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus.
CytoGenix Delivers Scaled-up synDNA(TM) Order to Customer.
CytoGenix and Eurogentec Align on synDNA(TM) Development.
CytoGenix to Present at 2007 International DNA Vaccines Conference in Spain.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles